STRS Ohio’s Altimmune ALT Stock Holding History

STRS Ohio’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,200	Closed	-$7.37K	–	1889
2024 Q3	$7.37K	Sell	1,200 -3,100	-72%	-$21K	﹤0.01%	1937
2024 Q2	$28.6K	Hold	4,300	–	–	﹤0.01%	1859
2024 Q1	$43K	Buy	+4,300	New	+$43.7K	﹤0.01%	1775
2017 Q2	–	Sell	-670	Closed	-$111K	–	1930
2017 Q1	$163K	Hold	670	–	–	﹤0.01%	1558
2016 Q4	$652K	Hold	670	–	–	﹤0.01%	1208
2016 Q3	$582K	Buy	670 +148	+28%	+$116K	﹤0.01%	1233
2016 Q2	$381K	Buy	+522	New	+$357K	﹤0.01%	1402

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

STRS Ohio's ALT Position: Q4 2024 in Review

STRS Ohio sold out of Altimmune (ALT) in Q4 2024, closing a stake of 1,200 shares — an estimated $7.37K sold.

STRS Ohio first reported a position in ALT in Q2 2016 and held it in 7 quarters. The position peaked at $652K in Q4 2016. 182 funds tracked by Wall St. Rank hold ALT as of Q4 2024.

STRS Ohio reported no remaining Altimmune position as of Q4 2024 after selling out during the quarter.
STRS Ohio sold 1,200 Altimmune shares in Q4 2024, an estimated $7.37K.
STRS Ohio first reported a position in Altimmune in Q2 2016 and held it in 7 quarters.
STRS Ohio's Altimmune position peaked at $652K in Q4 2016.
182 funds tracked by Wall St. Rank held Altimmune as of Q4 2024.

Based on STRS Ohio's 13F filing for Q4 2024, filed 28 May 2025.